ANTIBODY DRUG CONJUGATE COMPRISING NMT INHIBITOR AND ITS USE
Application
US20260083858A1
Kind: A1
Mar 26, 2026
Inventors
Robin CARR, Roberto SOLARI, Edward William TATE, Andrew Simon BELL, Roger BONNERT
Abstract
The present invention relates to ADCs comprising a NMT inhibitor conjugated to an antibody via a linker, and related uses.
CPC Classifications
A61K 47/6855
A61K 47/6803
A61K 47/6849
A61P 35/00
C07K 16/2887
C07K 16/32
Filing Date
2023-09-08
Application No.
19109326